El-Saied Melies, M., El Agwany, A., Hamed, H. (2023). ULTRASOUND VERSUS COMPUTED TOMOGRAPHY IN STAGING OF OVARIAN CANCER. ALEXMED ePosters, 5(3), 1-2. doi: 10.21608/alexpo.2023.220097.1635
Mahmoud El-Saied Melies; Ahmed Samy El Agwany; Heba Ahmed Mohamed Mahmoud Hamed. "ULTRASOUND VERSUS COMPUTED TOMOGRAPHY IN STAGING OF OVARIAN CANCER". ALEXMED ePosters, 5, 3, 2023, 1-2. doi: 10.21608/alexpo.2023.220097.1635
El-Saied Melies, M., El Agwany, A., Hamed, H. (2023). 'ULTRASOUND VERSUS COMPUTED TOMOGRAPHY IN STAGING OF OVARIAN CANCER', ALEXMED ePosters, 5(3), pp. 1-2. doi: 10.21608/alexpo.2023.220097.1635
El-Saied Melies, M., El Agwany, A., Hamed, H. ULTRASOUND VERSUS COMPUTED TOMOGRAPHY IN STAGING OF OVARIAN CANCER. ALEXMED ePosters, 2023; 5(3): 1-2. doi: 10.21608/alexpo.2023.220097.1635
ULTRASOUND VERSUS COMPUTED TOMOGRAPHY IN STAGING OF OVARIAN CANCER
2Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
Abstract
Ovarian cancer is the seventh most prevalent cancer among women worldwide and representing the second most common gynecological cancer and the leading cause of death of the female reproductive system cancers. Women often present with late-stage disease, in which 5-year survival rate of either 37% (stage III disease) or 25% (stage IV disease). Ovarian cancer is uncommon before the age of 40, but it rises sharply after that and peaks between the ages of 65 and 75. Its incidence and mortality rates, however, have been decreasing in recent decades, possible by the introduction of oral contraceptives, which, along with parity, are the best recognized protective factor for the disease. Late menopause and irregular menstrual cycles may also lower the risk, while the role of hormone replacement therapy in menopause and fertility treatments remains unknown. AIM OF THE WORK The aim of this study was to compare the diagnostic accuracy of ultrasound and CT for detecting pelvic and abdominal tumor spread in women with ovarian cancer.
View on SCiNiTO
Top